Vonafexor accepted as the generic name for EYP001 by the WHO

We are pleased to announce that the World Health Organization (WHO) has accepted the international non-proprietary name (INN, or generic name) vonafexor for our FXR agonist lead candidate previously referred to as EYP001.

Read next in 'Latest news'